Thrombotic microangiopathy in marginal kidneys after sirolimus use.
Pellé, Gaëlle; Xu, Ychen; Khoury, Noujoud; Mougenot, Béatrice; Rondeau, Eric.
Am J Kidney Dis
; 46(6): 1124-8, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16310579
Everolimus in combination with mycophenolate mofetil as pre- and post-transplantation immunosuppression after nonmyeloablative hematopoietic stem cell transplantation in canine littermates.
Plasma neutrophil gelatinase-associated lipocalin and worsening renal function during everolimus therapy after heart transplantation.
Severe stomatitis complicating immune-suppressive switch after cardiac transplantation.
Belatacept for kidney transplant recipients.
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients.
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.
JC polyomavirus nephropathy, a rare cause of transplant dysfunction: Case report and review of literature.
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study.